ATS guidelines for methacholine and exercise challenge testing.
暂无分享,去创建一个
[1] R. Effros. Endogenous airway acidification: implications for asthma pathology. , 2001, American journal of respiratory and critical care medicine.
[2] D. Cockcroft,et al. Calculation of Provocative Concentration Causing a 20% Fall in FEV1 , 2000 .
[3] B. Gaston,et al. Endogenous airway acidification. Implications for asthma pathophysiology. , 2000, American journal of respiratory and critical care medicine.
[4] M. Sears,et al. Comparison of two standardized methods of methacholine inhalation challenge in young adults , 2000 .
[5] J. Hankinson,et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. , 2000, American journal of respiratory and critical care medicine.
[6] M. Sears,et al. Comparison of two standardized methods of methacholine inhalation challenge in young adults. , 2000, The European respiratory journal.
[7] D. Cockcroft,et al. Calculation of provocative concentration causing a 20% fall in FEV(1): comparison of lowest vs highest post-challenge FEV(1). , 2000, Chest.
[8] S. Godfrey,et al. Cut-off points defining normal and asthmatic bronchial reactivity to exercise and inhalation challenges in children and young adults. , 1999, The European respiratory journal.
[9] W. Guggino. Cystic Fibrosis and the Salt Controversy , 1999, Cell.
[10] V. Koseoglu,et al. Acquired pseudocholinesterase deficiency after high-dose cyclophosphamide , 1999, Bone Marrow Transplantation.
[11] L. Ignarro,et al. Condensed expirate nitrite as a home marker for acute asthma , 1995, The Lancet.
[12] V. Popa. Physiologic factors affecting the discriminant ability of provocation doses to histamine. , 1994, Annals of allergy.
[13] S. Klebanoff,et al. Reactive nitrogen intermediates and antimicrobial activity: role of nitrite. , 1993, Free radical biology & medicine.
[14] D. Cockcroft,et al. Sensitivity and specificity of histamine PC20 determination in a random selection of young college students. , 1992, The Journal of allergy and clinical immunology.
[15] A. Bauman,et al. Repeatability of histamine bronchial challenge and comparability with methacholine bronchial challenge in a population of Australian schoolchildren. , 1991, The American review of respiratory disease.
[16] V. Popa,et al. Provocation dose and discriminant analysis in histamine bronchoprovocation. Are the current predictive data satisfactory? , 1988, Chest.
[17] P. Burney,et al. Comparison of histamine and methacholine for use in bronchial challenge tests in community studies. , 1988, Thorax.
[18] S. Vedal,et al. Asthma, asthmalike symptoms, chronic bronchitis, and the degree of bronchial hyperresponsiveness in epidemiologic surveys. , 1987, The American review of respiratory disease.
[19] R. Davies,et al. A comparison of histamine and methacholine bronchial challenges using the DeVilbiss 646 nebulizer and the Rosenthal-French dosimeter. , 1987, British journal of diseases of the chest.
[20] T. Poon-King,et al. LEUCOCYTE SUPPRESSION IN TREATMENT OF 72 PATIENTS WITH PARAQUAT POISONING , 1986, The Lancet.
[21] P. Valberg,et al. Deposition of aerosol in the respiratory tract. , 1979, The American review of respiratory disease.